Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier, Walter Prof. Dr. (1) Mathas, Stephan Dr. (4) Reich, Jens Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (24) Smith, Janice (1) Stein, Ulrike Prof. Dr. (5) Walther, Wolfgang Prof. Dr. (4) Wollert-Wulf, Brigitte (2) (-) Daniel, Peter Prof. Dr. (2) (-) Janz, Martin Dr. (4) (-) Lusatis, Simone (1) (-) Biologie maligner Lymphome (4) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Molekulare Zellbiologie und Gentherapie (1) Proteom Dynamik (2) (-) Translationale Onkologie solider Tumore (7) 1992 (2) 1993 (1) 1994 (1) 1996 (1) 1997 (1) 1998 (1) 1999 (1) 2000 (1) 2001 (3) 2002 (2) 2003 (8) 2004 (3) 2005 (4) (-) 2006 (11) 2007 (3) 2008 (7) 2009 (8) 2010 (3) 2011 (9) 2012 (5) 2013 (4) 2014 (2) 2015 (4) 2016 (2) 2017 (4) 2018 (2) 2019 (1) 2020 (5) 2021 (5) 2022 (5) 2023 (2) 11 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Lusatis, SimoneBiologie maligner LymphomeTranslationale Onkologie solider Tumore2006 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Dezember 2006 / Chirurg Minimalresiduale Tumorerkrankung bei gastrointestinalen Karzinomen : Prognoserelevanz und onkologisch-chirurgische Konsequenzen [Minimal residual tumor in gastrointestinal carcinoma: Relevance to prognosis and oncologic surgical consequences] S. Gretschel A. Bembenek T. Schulze W. Kemmner P.M. Schlag 01. Oktober 2006 / Am J Pathol H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling I. Nazarenko G. Kristiansen S. Fonfara R. Guenther C. Gieseler W. Kemmner R. Schaefer I. Petersen C. Sers 13. Juni 2006 / BMC Genomics Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression H. Pospisil A. Herrmann K. Butherus S. Pirson J.G. Reich W. Kemmner 01. Juni 2006 [Effect of cell surface sialic acid and their linkages on adhesion of mammary carcinoma cells] X.Y. Wang S.Q. Lin J.W. Li W. Kemmner Y.Q. Ding 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 10. Mai 2006 / BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 10. Januar 2006 / J Clin Oncol Vascular endothelial growth factor-D and its receptor VEGFR-3: Two novel independent prognostic markers in gastric adenocarcinoma S. Juettner C. Wissmann T. Joens M. Vieth J. Hertel S. Gretschel P.M. Schlag W. Kemmner M. Hoecker Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Dezember 2006 / Chirurg Minimalresiduale Tumorerkrankung bei gastrointestinalen Karzinomen : Prognoserelevanz und onkologisch-chirurgische Konsequenzen [Minimal residual tumor in gastrointestinal carcinoma: Relevance to prognosis and oncologic surgical consequences] S. Gretschel A. Bembenek T. Schulze W. Kemmner P.M. Schlag
01. Oktober 2006 / Am J Pathol H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling I. Nazarenko G. Kristiansen S. Fonfara R. Guenther C. Gieseler W. Kemmner R. Schaefer I. Petersen C. Sers
13. Juni 2006 / BMC Genomics Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression H. Pospisil A. Herrmann K. Butherus S. Pirson J.G. Reich W. Kemmner
01. Juni 2006 [Effect of cell surface sialic acid and their linkages on adhesion of mammary carcinoma cells] X.Y. Wang S.Q. Lin J.W. Li W. Kemmner Y.Q. Ding
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
10. Mai 2006 / BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
10. Januar 2006 / J Clin Oncol Vascular endothelial growth factor-D and its receptor VEGFR-3: Two novel independent prognostic markers in gastric adenocarcinoma S. Juettner C. Wissmann T. Joens M. Vieth J. Hertel S. Gretschel P.M. Schlag W. Kemmner M. Hoecker